A randomized controlled trial of a multicomponent, targeted, low-literacy educational intervention compared with a nontargeted intervention to boost colorectal cancer screening with fecal immunochemical testing in community clinics

Cancer

Volumn 123, Issue 8, 2017, Pages 1390-1400

  Davis, Stacy N ^a,b   Christy, Shannon M ^b,c   Chavarria, Enmanuel A ^b,c   Abdulla, Rania ^b   Sutton, Steven K ^b,c   Schmidt, Alyssa R ^b   Vadaparampil, Susan T ^b   Quinn, Gwendolyn P ^b,c   Simmons, Vani N ^b,c   Ufondu, Chukwudi B ^d   Ravindra, Chitra ^d   Schultz, Ida ^e   Roetzheim, Richard G ^b,c   Shibata, David ^b,c,f   Meade, Cathy D ^b,c   Gwede, Clement K ^b,c  

^a RUTGERS SCHOOL OF PUBLIC HEALTH   (United States)

^b H LEE MOFFITT CANCER CENTER AND RESEARCH INSTITUTE   (United States)

^c UNIVERSITY OF SOUTH FLORIDA   (United States)

^d FLORIDA DEPARTMENT OF HEALTH   (United States)

^e Premier Community HealthCare Group Inc   (United States)

^f UNIVERSITY OF TENNESSEE HEALTH SCIENCE CENTER   (United States)

Author keywords

colorectal cancer; early detection of cancer; fecal immunochemical test; health promotion; intervention studies; medically underserved

Indexed keywords

ADULT; AFRICAN AMERICAN; AGED; ARTICLE; AWARENESS; CANCER AWARENESS SCORE; CANCER CONTROL; CANCER PREVENTION; CANCER RISK; CANCER SCREENING; CLINICAL EFFECTIVENESS; CLINICAL STUDY; COLONOSCOPY; COLORECTAL CANCER; COMMUNITY CARE; CONTROLLED STUDY; DEMOGRAPHY; EDUCATIONAL STATUS; ETHNICITY; FAMILY HISTORY; FECAL IMMUNOCHEMICAL TESTING; FEMALE; HEALTH BELIEF; HEALTH CARE SYSTEM; HEALTH INSURANCE; HEALTH LITERACY; HISPANIC; HUMAN; IMMUNOCHEMISTRY; LOWEST INCOME GROUP; MAJOR CLINICAL STUDY; MALE; MULTICOMPONENT STUDY; PATIENT PREFERENCE; PHYSICAL EXAMINATION; POLYP; PREDICTION; RANDOMIZED CONTROLLED TRIAL; RECTUM CANCER; RELIGION; SELF CONCEPT; SOCIAL SUPPORT; SOCIOECONOMICS; TRUST; CHEMISTRY; COLORECTAL NEOPLASMS; EARLY CANCER DIAGNOSIS; FECES; MASS SCREENING; MIDDLE AGED; ODDS RATIO; PATIENT EDUCATION; RISK FACTOR;

AGED; COLORECTAL NEOPLASMS; EARLY DETECTION OF CANCER; FECES; FEMALE; HUMANS; MALE; MASS SCREENING; MIDDLE AGED; ODDS RATIO; PATIENT EDUCATION AS TOPIC; RISK FACTORS;

EID: 85006246878     PISSN: 0008543X     EISSN: 10970142     Source Type: Journal    
DOI: 10.1002/cncr.30481     Document Type: Article

References (64)

1. American Cancer Society. Colorectal Cancer Facts & Figures: 2014-2016. Atlanta, GA: American Cancer Society; 2014.
2. Centers for Disease Control and Prevention. [Vital Signs: Colorectal Cancer Screening Among Adults Aged 50-75 Years-United States, 2008]. MMWR 2010;59 (Early Release):[1–5].
3. Smith RA, Cokkinides V, Brawley OW. Cancer screening in the United States, 2009: a review of current American Cancer Society guidelines and issues in cancer screening. CA Cancer J Clin. 2009;59:27–41.
4. Shapiro JA, Klabunde CN, Thompson TD, Nadel MR, Seeff LC, White A. Patterns of colorectal cancer test use, including CT colonography, in the 2010 National Health Interview Survey. Cancer Epidemiol Biomarkers Prev. 2012;21:895–904.
5. Shih YC, Elting LS, Levin B. Disparities in colorectal screening between US-born and foreign-born populations: evidence from the 2000 National Health Interview Survey. J Cancer Educ. 2008;23:18–25.
6. Seeff LC, Nadel MR, Klabunde CN, et al. Patterns and predictors of colorectal cancer test use in the adult U.S. population. Cancer. 2004;100:2093–2103.
7. Goldman SN, Liss DT, Brown T, et al. Comparative effectiveness of multifaceted outreach to initiate colorectal cancer screening in community health centers: a randomized controlled trial. J Gen Intern Med. 2015;30:1178–1184.
8. Berkowitz Z, Hawkins NA, Peipins LA, White MC, Nadel MR. Beliefs, risk perceptions, and gaps in knowledge as barriers to colorectal cancer screening in older adults. J Am Geriatr Soc. 2008;56:307–314.
9. Gwede CK, Davis SN, Quinn GP, et al; Tampa Bay Community Cancer Network (TBCCN) Partners. Making it work: health care provider perspectives on strategies to increase colorectal cancer screening in federally qualified health centers. J Cancer Educ. 2013;28:777–783.
10. Williams R, White P, Nieto J, Vieira D, Francois F, Hamilton F. Colorectal cancer in African Americans: an update. Clin Transl Gastroenterol. 2016;7:e185.
11. Khankari K, Eder M, Osborn CY, et al. Improving colorectal cancer screening among the medically underserved: a pilot study within a federally qualified health center. J Gen Intern Med. 2007;22:1410–1414.
12. Dharni N, Armstrong D, Chung-Faye G, Wright AJ. Factors influencing participation in colorectal cancer screening-a qualitative study in an ethnic and socio-economically diverse inner city population [published online ahead of print August 22, 2016]. Health Expect. doi: 10.1111/hex.12489.
13. Smith SG, McGregor LM, Raine R, Wardle J, von Wagner C, Robb KA. Inequalities in cancer screening participation: examining differences in perceived benefits and barriers. Psychooncology. 2016;25:1168–1174.
14. Basch CH, Basch CE, Zybert P, Wolf RL. Fear as a barrier to asymptomatic colonoscopy screening in an urban minority population with health insurance. J Community Health. 2016;41:818–824.
15. Schoenberg NE, Eddens K, Jonas A, et al. Colorectal cancer prevention: perspectives of key players from social networks in a low-income rural US region. Int J Qual Stud Health Well-being. 2016;11:30396.
16. Daly JM, Levy BT, Moss CA, Bay CP. System strategies for colorectal cancer screening at federally qualified health centers. Am J Public Health. 2015;105:212–219.
17. Health Resources and Services Administration. Health Center Fact Sheet. Washington, DC: Health Resources and Services Administration; 2014.
18. Wilschut JA, Steyerberg EW, van Leerdam ME, Lansdorp-Vogelaar I, Habbema JD, van Ballegooijen M. How much colonoscopy screening should be recommended to individuals with various degrees of family history of colorectal cancer? Cancer. 2011;117:4166–4174.
19. Gupta S, Halm EA, Rockey DC, et al. Comparative effectiveness of fecal immunochemical test outreach, colonoscopy outreach, and usual care for boosting colorectal cancer screening among the underserved: a randomized clinical trial. JAMA Intern Med. 2013;173:1725–1732.
20. Davis TC, Arnold CL, Bennett CL, et al. Strategies to improve repeat fecal occult blood testing cancer screening. Cancer Epidemiol Biomarkers Prev. 2014;23:134–143.
21. Myers RE, Sifri R, Hyslop T, et al. A randomized controlled trial of the impact of targeted and tailored interventions on colorectal cancer screening. Cancer. 2007;110:2083–2091.
22. Coronado GD, Golovaty I, Longton G, Levy L, Jimenez R. Effectiveness of a clinic-based colorectal cancer screening promotion program for underserved Hispanics. Cancer. 2011;117:1745–1754.
23. Potter MB, Somkin CP, Ackerson LM, et al. The FLU-FIT program: an effective colorectal cancer screening program for high volume flu shot clinics. Am J Manag Care. 2011;17:577–583.
24. Inadomi JM, Vijan S, Janz NK, et al. Adherence to colorectal cancer screening: a randomized clinical trial of competing strategies. Arch Intern Med. 2012;172:575–582.
25. Walsh JM, Salazar R, Nguyen TT, et al. Healthy colon, healthy life: a novel colorectal cancer screening intervention. Am J Prev Med. 2010;39:1–14.
26. Lasser KE, Murillo J, Lisboa S, et al. Colorectal cancer screening among ethnically diverse, low-income patients: a randomized controlled trial. Arch Intern Med. 2011;171:906–912.
27. Singal AG, Gupta S, Tiro JA, et al. Outreach invitations for FIT and colonoscopy improve colorectal cancer screening rates: a randomized controlled trial in a safety-net health system. Cancer. 2016;122:456–463.
28. Katz ML, Fisher JL, Fleming K, Paskett ED. Patient activation increases colorectal cancer screening rates: a randomized trial among low-income minority patients. Cancer Epidemiol Biomarkers Prev. 2012;21:45–52.
29. Gupta S, Sussman DA, Doubeni CA, et al. Challenges and possible solutions to colorectal cancer screening for the underserved. J Natl Cancer Inst. 2014;106:dju032.
30. Thomson MD, Hoffman-Goetz L. Readability and cultural sensitivity of web-based patient decision aids for cancer screening and treatment: a systematic review. Med Inform Internet Med. 2007;32:263–286.
31. Gwede CK, William CM, Thomas KB, et al. Exploring disparities and variability in perceptions and self-reported colorectal cancer screening among three ethnic subgroups of U.S. Blacks. Oncol Nurs Forum. 2010;37:581–591.
32. Meade CD, Menard JM, Luque JS, Martinez-Tyson D, Gwede CK. Creating community-academic partnerships for cancer disparities research and health promotion. Health Promot Pract. 2011;12:456–462.
33. Simmons VN, Klasko LB, Fleming K, et al; Tampa Bay Community Cancer Network Community Partners. Participatory evaluation of a community-academic partnership to inform capacity-building and sustainability. Eval Program Plann. 2015;52:19–26.
34. Tiro JA, Vernon SW, Hyslop T, Myers RE. Factorial validity and invariance of a survey measuring psychosocial correlates of colorectal cancer screening among African Americans and Caucasians. Cancer Epidemiol Biomarkers Prev. 2005;14:2855–2861.
35. McQueen A, Tiro JA, Vernon SW. Construct validity and invariance of four factors associated with colorectal cancer screening across gender, race, and prior screening. Cancer Epidemiol Biomarkers Prev. 2008;17:2231–2237.
36. Vernon SW, Myers RE, Tilley BC. Development and validation of an instrument to measure factors related to colorectal cancer screening adherence. Cancer Epidemiol Biomarkers Prev. 1997;6:825–832.
37. Volk RJ, Jibaja-Weiss ML, Hawley ST, et al. Entertainment education for prostate cancer screening: a randomized trial among primary care patients with low health literacy. Patient Educ Couns. 2008;73:482–489.
38. Kreuter MW, Green MC, Cappella JN, et al. Narrative communication in cancer prevention and control: a framework to guide research and application. Ann Behav Med. 2007;33:221–235.
39. Gwede CK, Koskan AM, Quinn GP, et al; Tampa Bay Community Cancer Network (TBCCN). Patients' perceptions of colorectal cancer screening tests and preparatory education in federally qualified health centers. J Cancer Educ. 2015;30:294–300.
40. Gwede CK, Jean-Francois E, Quinn GP, et al; Tampa Bay Community Cancer Network partners. Perceptions of colorectal cancer among three ethnic subgroups of US blacks: a qualitative study. J Natl Med Assoc. 2011;103:669–680.
41. Bass PF 3rd, Wilson JF, Griffith CH. A shortened instrument for literacy screening. J Gen Intern Med. 2003;18:1036–1038.
42. US Department of Health and Human Services, National Cancer Institute. Health Information National Trends Survey (HINTS). Washington, DC: Department of Health and Human Services; 2009.
43. Rose A, Peters N, Shea JA, Armstrong K. Development and testing of the health care system distrust scale. J Gen Intern Med. 2004;19:57–63.
44. SAS Institute Inc. Statistical Analysis Software. Cary, NC: SAS Institute Inc; 2013.
45. Jerant A, Kravitz RL, Sohler N, et al. Sociopsychological tailoring to address colorectal cancer screening disparities: a randomized controlled trial. Ann Fam Med. 2014;12:204–214.
46. Larkey LK, McClain D, Roe DJ, et al. Randomized controlled trial of storytelling compared to a personal risk tool intervention on colorectal cancer screening in low-income patients. Am J Health Promot. 2015;30:e59–e70.
47. Greiner KA, Daley CM, Epp A, et al. Implementation intentions and colorectal screening: a randomized trial in safety-net clinics. Am J Prev Med. 2014;47:703–714.
48. Krok-Schoen JL, Young GS, Pennell ML, et al. Testing Interventions to Motivate and Educate (TIME): a multi-level intervention to improve colorectal cancer screening. Prev Med Rep. 2015;2:306–313.
49. Christy SM, Davis SN, Williams KR, et al. A community-based trial of educational interventions with fecal immunochemical tests for colorectal cancer screening uptake among blacks in community settings. Cancer. 2016;122:3288–3296.
50. Vernon SW, Bartholomew LK, McQueen A, et al. A randomized controlled trial of a tailored interactive computer-delivered intervention to promote colorectal cancer screening: sometimes more is just the same. Ann Behav Med. 2011;41:284–299.
51. Jandorf L, Braschi C, Ernstoff E, et al. Culturally targeted patient navigation for increasing African Americans' adherence to screening colonoscopy: a randomized clinical trial. Cancer Epidemiol Biomarkers Prev. 2013;22:1577–1587.
52. US Department of Health and Human Services. Healthy People 2020 Leading Health Indicators: Clinical Preventive Services. Washington, DC: Office of Disease Prevention and Health Promotion, US Department of Health and Human Services; 2014.
53. Centers for Disease Control and Prevention. Colorectal cancer control program. http://www.cdc.gov/cancer/crccp/pdf/CRCCP_FactSheet.pdf. Accessed February 19, 2016.
54. Potter MB, Walsh JM, Yu TM, Gildengorin G, Green LW, McPhee SJ. The effectiveness of the FLU-FOBT program in primary care: a randomized trial. Am J Prev Med. 2011;41:9–16.
55. Tu SP, Taylor V, Yasui Y, et al. Promoting culturally appropriate colorectal cancer screening through a health educator: a randomized controlled trial. Cancer. 2006;107:959–966.
56. Davis T, Arnold C, Rademaker A, et al. Improving colon cancer screening in community clinics. Cancer. 2013;119:3879–3886.
57. Nash D, Azeez S, Vlahov D, Schori M. Evaluation of an intervention to increase screening colonoscopy in an urban public hospital setting. J Urban Health. 2006;83:231–243.
58. Nguyen BH, McPhee SJ, Stewart SL, Doan HT. Effectiveness of a controlled trial to promote colorectal cancer screening in Vietnamese Americans. Am J Public Health. 2010;100:870–876.
59. Ritvo PG, Myers RE, Paszat LF, et al. Personal navigation increases colorectal cancer screening uptake. Cancer Epidemiol Biomarkers Prev. 2015;24:506–511.
60. Healthcare Effectiveness Data and Information Set (HEDIS). Summary Table of Measures, Product Lines and Changes. http://www.ncqa.org/Portals/0/HEDISQM/HEDIS2016/HEDIS%202016%20List%20of%20Measures.pdf. Accessed February 19, 2016.
61. US Department of Health and Human Services. Reporting Instructions. Washington, DC: US Department of Health and Human Services; 2015.
62. Arnold CL, Rademaker A, Wolf MS, et al. Final results of a 3-year literacy-informed intervention to promote annual fecal occult blood test screening. J Community Health. 2016;41:724–731.
63. Fenton JJ, Elmore JG, Buist DS, Reid RJ, Tancredi DJ, Baldwin LM. Longitudinal adherence with fecal occult blood test screening in community practice. Ann Fam Med. 2010;8:397–401.
64. Gellad ZF, Stechuchak KM, Fisher DA, et al. Longitudinal adherence to fecal occult blood testing impacts colorectal cancer screening quality. Am J Gastroenterol. 2011;106:1125–1134.